Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter study-Reference-Cited by-同舟云学术

Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter study

Published:1988-11 Issue:15 Volume:62 Page:J35-J43
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Tikkanen Matti J.,Helve Eero,Jäättelä Antti,Kaarsalo Esko,Lehtonen Aapo,Malbecq William,Oksa Heikki,Pääkkönen Paavo,Salmi Jorma,Veharanta Tapio,Viikari Jorma,Äärynen Matti

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. The Lipid Research Clinics Primary Prevention Trial results I and II;Lipid Research Clinics Program;JAMA,1984

2. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia;Frick;N Engl J Med,1987

3. Lipid alterations and decline in incidence of coronary heart disease in the Helsinki Heart Study;Manninen;JAMA,1988

4. Mevinolin, a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol lowering agent;Alberts,1980

5. Clinical results with gemfibrozil and background to the Helsinki Heart Study;Manninen;Am J Cardiol,1983

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials;PLOS ONE;2021-02-09

2. Lipid-Lowering Therapy with Statins for the Primary and Secondary Prevention of Cardiovascular Disease;Cardiology Clinics;2011-02

3. Cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam;Health Policy and Planning;2010-09-15

4. Influence of Brain Natriuretic Peptide on Phenotypic Change of Cerebral Vasculature;Cerebral Vasospasm;2001

5. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial;Atherosclerosis;1999-10